Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
Stock Information for SI-BONE Inc.
Loading
Please wait while we load your information from QuoteMedia.